http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5246701-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7449ca99fbf1c556219fe28876cbf2a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60a6b201e054ae93d990c682d8600109
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-805
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-247
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715
filingDate 1991-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fb58857b78e7b583662dc5cd7d255f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6b1d55e8a41e4fa42c86597cccd7b0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4470480b9fce00a5a7c908fb82b3784c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b8e9fd9992c991dd622ae9d73687d1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b005f9e7a1c6b3b5ff51792ba6344ca7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d86a50f0ee05cace302252e3fa917f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bbd82f51a019ff881fe48a4ba124731
publicationDate 1993-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5246701-A
titleOfInvention Method for inhibiting production of IgE by using IL-9 inhibitors
abstract A method for inhibiting production of IgE, and a method for enhancing production of IgG are taught. The methods are linked to the role of interleukin 9 in antibody production. Specifically, production of IgG is potentiated by administering either to a subject or a cell culture a combination of interleukin 4 and interleukin 9. Production of IgE is inhibited by administering an amount of an interleukin 9 inhibitor to a subject.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7507706-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6037149-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8221752-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7192578-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008039401-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7553487-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7943342-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6548655-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6645492-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-721908-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5962269-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5767065-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6602850-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6261559-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006073148-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004219149-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7208292-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7615213-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006063228-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007190609-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009274705-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7919248-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006205035-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011224406-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7056698-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6248714-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004076607-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5908839-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008299073-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7384767-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7501121-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009068195-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009105453-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005277126-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009098142-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010129360-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7704710-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7700088-B2
priorityDate 1990-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9108774-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4578335-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5116951-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8909621-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226456292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129079762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24187255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4686862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129763036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421590

Total number of triples: 85.